Neutralizing antibodies to hepatitis C virus in perinatally infected children followed up prospectively

Journal of Infectious Diseases

Volumn 204, Issue 11, 2011, Pages 1741-1745

  Meunier, Jean Christophe ^a   Bukh, Jens ^a,b   Diaz, Giacomo ^c   Tovo, Pier Angelo ^d   Casadei, Anna Maria ^e   Quinti, Isabella ^f   Iorio, Raffaele ^g   Emerson, Suzanne ^a   Purcell, Robert H ^a   Farci, Patrizia ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b Mental Health Center Glostrup   (Denmark)

^c UNIVERSITY OF CAGLIARI   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e Department of Pediatrics ^*  (Italy)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY;

ACUTE HEPATITIS; ARTICLE; CHILD; CLINICAL ARTICLE; CROSS REACTION; DISEASE COURSE; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION CONTROL; LONGITUDINAL STUDY; MALE; NONHUMAN; PERINATAL INFECTION; PRIORITY JOURNAL; PROGNOSIS; VERTICAL TRANSMISSION; VIRAL CLEARANCE; VIRUS PARTICLE; VIRUS TRANSMISSION;

ADOLESCENT; ALANINE TRANSAMINASE; ANTIBODIES, NEUTRALIZING; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LONGITUDINAL STUDIES; MALE; PROSPECTIVE STUDIES; RNA, VIRAL; STATISTICS, NONPARAMETRIC; VIREMIA;

EID: 80155194163     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir631     Document Type: Article

References (15)

1. Tovo PA, Pembrey LJ, Newell ML. Persistence rate and progression of vertically acquired hepatitis C infection. European Paediatric Hepatitis C Virus Infection. J Infect Dis 2000; 181:419-24.
2. Resti M, Jara P, Hierro L, et al. Clinical features and progression of perinatally acquired hepatitis C virus infection. J Med Virol 2003; 70:373-7.
3. Farci P, Quinti I, Farci S, et al. Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively. Proc Natl Acad Sci U S A 2006; 103:8475-80.
4. Zeisel MB, Fafi-Kremer S, Fofana I, et al. Neutralizing antibodies in hepatitis C virus infection. World J Gastroenterol 2007; 13: 4824-30.
5. Meunier JC, Engle RE, Faulk K, et al. Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1. Proc Natl Acad Sci U S A 2005; 102:4560-5.
6. Bartosch B, Bukh J, Meunier JC, et al. In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes. Proc Natl Acad Sci U S A 2003; 100: 14199-04.
7. Logvinoff C, Major ME, Oldach D, et al. Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proc Natl Acad Sci U S A 2004; 101:10149-54.
8. Steinmann D, Barth H, Gissler B, et al. Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C. J Virol 2004; 78:9030-40.
9. Dowd KA, Hershow RC, Yawetz S, et al. Maternal neutralizing antibody and transmission of hepatitis C virus to infants. J Infect Dis 2008; 198:1651-5.
10. Fafi-Kremer S, Fofana I, Soulier E, et al. Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation. J Exp Med 2010; 207:2019-31.
11. Tarr AW, Urbanowicz RA, Hamed MR, et al. Hepatitis C virus (HCV) patient-derived glycoproteins exhibit marked differences in their susceptibility to serum neutralizing antibodies: Genetic subtype defines antigenic but not neutralization serotype. J Virol 2011; 85:4246-57.
12. Von Hahn T, Yoon JC, Alter H, et al. Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. Gastroenterology 2007; 132:667-78.
13. Pestka JM, ZeiselMB, Blaser E, et al. Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C. Proc Natl Acad Sci U S A 2007; 104:6025-30.
14. Dowd KA, Netski DM, Wang X-H, Cox AL, Ray SC. Selection pressure from neutralizing antibodies drive sequence evolution during acute infection with hepatitis C virus. Gastroenterology 2009; 136:2377-86.
15. Farci P, Alter HJ, Wong DC, et al. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci U S A 1994; 91:7792-6.